Article
Kinetic and structural analysis for potent antifolate inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and human dihydrofolate reductases and their active-site variants.
Antimicrobial agents and chemotherapy - 1 Jun 2013
Cody Vivian, Pace Jim, Queener Sherry F, Adair Ona O, Gangjee Aleem
Abstract excerpt
A major concern of immunocompromised patients, in particular those with AIDS, is susceptibility to infection caused by opportunistic pathogens such as Pneumocystis jirovecii, which is a leading cause of pneumonia in immunocompromised patients. We report the first kinetic and structural data for 2,4-diamino-6-[(2',5'-dichloro anilino)methyl]pyrido[2,3-d]pyrimidine (OAAG324), a potent inhibitor of dihydrofolate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
